1. Synthetic Affibody Molecules: A Novel Class of Affinity Ligands for Molecular Imaging of HER2-Expressing Malignant Tumors
   Anna Orlova et al, 2007, Cancer Research CrossRef
2. Over-Expression of TBL1XR1 Indicates Poor Prognosis of Serous Epithelial Ovarian Cancer
   Ming Ma et al, 2017, The Tohoku Journal of Experimental Medicine CrossRef
3. Genetic and epigenetic alterations in human cancers
   G. V. Gerashchenko et al, 2024, Biopolymers and Cell CrossRef
4. Biochip for K-ras Mutation Screening in Ovarian Cancer
   Gerhild Fabjani et al, 2005, Clinical Chemistry CrossRef
5. TRRAP stimulates the tumorigenic potential of ovarian cancer stem cells
   Kyung Taek Kang et al, 2018, BMB Reports CrossRef
6. Identifying the Most Appropriate Pattern for Identification of Gene Expression Changes in Ovarian Cancer Using Microarray
   Massoume Eskandari et al, 2019, Iranian Red Crescent Medical Journal CrossRef
7. Clinical Significance of the TK1-Specific Activity in the Early Detection of Ovarian Cancer
   Joško Osredkar et al, 2024, Oncology CrossRef
8. Unveiling Crucial Proteins in Zone 2 of the Human Protein Interaction Network: Implications for Cancer Research and Therapeutic Targeting
   Emad Fadhal, 2023, The Open Bioinformatics Journal CrossRef
9. Mechanism of inhibition of theDrosophilaand mammalian EGF receptors by the transmembrane protein Kekkon 1
   Christian Ghiglione et al, 2003, Development CrossRef
10. KLF6-SV1 Is a Novel Antiapoptotic Protein That Targets the BH3-Only Protein NOXA for Degradation and Whose Inhibition Extends Survival in an Ovarian Cancer Model
    Analisa DiFeo et al, 2009, Cancer Research CrossRef
11. Mining Featured Biomarkers Linked with Epithelial Ovarian Cancer Based on Bioinformatics
    null null et al, 2019, Diagnostics CrossRef
12. The Impact of CRISPR-Cas9 on Age-related Disorders: From Pathology to Therapy
    Allen Caobi et al, 2020, Aging and disease CrossRef
13. Performance Comparisons between Unsupervised Clustering Techniques for Microarray Data Analysis on Ovarian Cancer
    Meng-Hsiun Tsai et al, 2006, 2006 IEEE International Conference on Systems, Man and Cybernetics CrossRef
14. Enhanced Susceptibility to Chemical Induction of Ovarian Tumors in Mice with a Germ Line p53 Mutation
    Yian Wang et al, 2008, Molecular Cancer Research CrossRef
15. DNA Hypomethylation and Ovarian Cancer Biology
    Martin Widschwendter et al, 2004, Cancer Research CrossRef
16. Radionuclide Therapy of HER2-Positive Microxenografts Using a 177Lu-Labeled HER2-Specific Affibody Molecule
    Vladimir Tolmachev et al, 2007, Cancer Research CrossRef
17. Final Results of a Phase II Study of Bevacizumab, Cisplatin and Pemetrexed as First-Line Therapy for Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer
    Guillermo López Vivanco et al, 2016, Journal of Cancer Therapy CrossRef
18. Analysis of Gene Expression in Early-Stage Ovarian Cancer
    Sergio Marchini et al, 2008, Clinical Cancer Research CrossRef
19. Patterns of Gene Expression in Different Histotypes of Epithelial Ovarian Cancer Correlate with Those in Normal Fallopian Tube, Endometrium, and Colon
    Rebecca T. Marquez et al, 2005, Clinical Cancer Research CrossRef
20. Activation of Antioxidant Pathways in Ras-Mediated Oncogenic Transformation of Human Surface Ovarian Epithelial Cells Revealed by Functional Proteomics and Mass Spectrometry
    Travis W. Young et al, 2004, Cancer Research CrossRef
21. Epigenetic Inactivation of TMS1/ASC in Ovarian Cancer
    Katsuhiko Terasawa et al, 2004, Clinical Cancer Research CrossRef
22. Epithelial ovarian cancer: An overview
    Arpita Desai, 2014, World Journal of Translational Medicine CrossRef